[1] |
LIU Qi, CHANG Cai, LI Jiawei.
Research progress on the correlation between imaging features and the molecular subtype, histopathology, clinical prognosis of ductal carcinoma in situ of the breast
[J]. China Oncology, 2024, 34(2): 201-209.
|
[2] |
XUE Liqiong, GUO Ye, CHEN Libo.
Expert consensus on the management of adverse events in patients receiving targeted agents for advanced thyroid cancer (2023 edition)
[J]. China Oncology, 2023, 33(9): 879-888.
|
[3] |
ZHANG Haoting, ZHENG Jing, FU Mengjiao, ZHOU Jianying.
Research progress on thyroid dysfunction induced by immunotherapy for lung cancer
[J]. China Oncology, 2023, 33(7): 701-706.
|
[4] |
YUAN Xinyue, YAO Yao, CHENG Shuai, ZHENG Xin, ZHANG Yuan.
Clinical study on high-risk factors for contralateral lymph node metastasis in unilateral papillary thyroid carcinoma
[J]. China Oncology, 2023, 33(6): 619-628.
|
[5] |
QU Ning, WANG Yuting, MA Ben, WANG Yu.
Advances in basic research, clinical diagnosis and treatment of thyroid cancer in 2022
[J]. China Oncology, 2023, 33(5): 423-430.
|
[6] |
SHI Rongliang, ZHANG Tingting, WANG Yu, NI Zhaoxian, WANG Hui, WANG Yulong, WEI Wenjun, XIANG Jun, QU Ning, LU Zhongwu, FAN Juan, GU Weijin, JI Qinghai.
Clinical application analysis of Da Vinci Xi robot in thyroid surgery using a gasless, unilateral axillary approach
[J]. China Oncology, 2023, 33(11): 1018-1025.
|
[7] |
QU Yiping, HOU Peng.
Genetic characteristics and prognosis of metastatic thyroid cancer in children
[J]. China Oncology, 2022, 32(5): 373-379.
|
[8] |
SUN Di, SUN Yuqing, ZHANG Xin, HUANG Lisha, LIN Yansong.
The relationship between genetic characteristics and clinical characteristics and the efficacy of 131I therapy in children and adolescents with locally advanced or metastatic differentiated thyroid cancer
[J]. China Oncology, 2022, 32(5): 380-387.
|
[9] |
DENG Shuting, FENG Yuan, QIAN Kai, GUO Kai, WANG Zhuoying.
Meta-analysis of the association between gene alterations and distant metastasis of differentiated thyroid carcinoma in children and adolescents
[J]. China Oncology, 2022, 32(5): 388-396.
|
[10] |
LIU Jia, LI Guanghan, GAO Luying, ZHANG Zijie, WANG Ying, XIONG Ying, ZHANG Bo.
Establishment and test of graded diagnostic model of thyroid cancer in children and adolescents
[J]. China Oncology, 2022, 32(5): 397-403.
|
[11] |
QI Mengfang, TIAN Tian, HUANG Rui.
Clinicopathological characteristics and 131I treatment of differentiated thyroid carcinoma in children and adolescents of different age groups
[J]. China Oncology, 2022, 32(5): 404-409.
|
[12] |
GUO Wenting, MU Zhuanzhuan, LI Zheng, ZHANG Yingqiang, JIN Xiaona, LIN Yansong.
Clinical outcome of 131I therapy in differentiated thyroid cancer patients with suspicious high thyroglobulin concentration
[J]. China Oncology, 2022, 32(5): 410-416.
|
[13] |
Expert Committee of Nuclear Medicine, Chinese society of Clinical Oncology, Expert Committee of Thyroid Cancer, Chinese society of Clinical Oncology, Committee of Thyroid Disease Society, China International Exchange and Promotive Association for Medical and Health Care, Committee of Thyroid Disease Prevention and Treatment Society, China Population Culture Promotion Association.
Expert consensus on management of differentiated thyroid carcinoma in children and adolescents (2022 edition)
[J]. China Oncology, 2022, 32(5): 451-468.
|
[14] |
MEI Xiaoran, FENG Fang, WANG Hui, WEI Zhixiao.
Analysis of therapeutic response of iodine positive metastasis lymph nodes in differentiated thyroid cancer after 131I treatment
[J]. China Oncology, 2022, 32(11): 1091-1097.
|
[15] |
CHEN Guo , HAN Pengli , CHEN Keru , LI Mingchuang , ZHANG Qingsong , CHEN Zheng , DONG Hanhua , QIAN Yuejun , LÜ Jing .
Molecular mechanism of miR-19b-3p regulating apoptosis of medullary thyroid cancer cells by targeting MTUS1
[J]. China Oncology, 2021, 31(5): 390-396.
|